Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Eli Lilly

Eli Lilly stock has crushed the broader markets in the past 10 years. But should you buy LLY at current levels, given its lofty valuation?

Barchart

Drug used in diabetes treatment Mounjaro helped dieters shed 60 pounds, study finds

A new study finds that the medicine in the diabetes drug Mounjaro helped people with obesity or who are overweight lose at least a quarter of their body weight

The Independent UK

Stock Market Rallies, Hits Resistance; Novo Nordisk, JPMorgan, Exxon In Focus: Weekly Review

The major indexes rallied for the week, but hit resistance at key levels amid weak stock market breadth. Novo Nordisk, JPMorgan, Exxon were in focus.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Futures Rise: Market Rally At Key Levels As Inflation Data Looms; Novo Nordisk Soars

The Nasdaq is just above its 50-day line with the CPI inflation report due. Novo Nordisk soared on news that slammed medtech stocks.

Investors Business Daily

9 'Unstoppable' Stocks Deliver Big Gains And No Pain To Investors

Risk and reward are supposed to be attached at the hip for S&P 500 stocks. But a small group of stocks are delivering all gain and no pain.

Investors Business Daily

Novo Nordisk, Eli Lilly leap as Ozempic shows promise in kidney patient treatment

Ozempic, the diabetes treatment often prescribed for weight loss, is also proving highly effective in treating patients with chronic kidney disease.

The Street

Weight-Loss Drugs Aren't To Blame For The Snack Pullback. Pepsi Offers This Reason.

Weight-loss drugs aren't the reason for suppressed shopping cart spending in a shaky economy, Pepsi executives say.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Futures Fall, Oil Prices Spike After Hamas Attack

Futures fell and crude oil prices spiked following the Hamas attack on Israel. Nvidia leads 11 stocks flashing buy signals after Friday's bullish upside reversal.

Investors Business Daily

The Point At Which IBD Stock Of The Day Eli Lilly Could Become Actionable Again

Eli Lilly is Friday's IBD Stock Of The Day. After announcing an acquisition, Eli Lilly stock is bounding off its 50-day moving average.

Investors Business Daily

US nutrition panel’s ties to top food giants revealed in new report

Transparency group US Right to Know finds members linked to Nestlé, Coca-Cola and others, raising conflict-of-interest questions

The Guardian - US

Dow Jones Futures Rise: Jobs Report Due; Tesla Cuts Model 3, Y Prices Again

The jobs report is key for a struggling market rally attempt. Tesla cut Model 3 and Model Y prices again.

Investors Business Daily

Why Eli Lilly's $1.4 Billion Takeover Is A Boon For More Than Just Point Biopharma

Eli Lilly said Tuesday it will buy cancer specialist Point Biopharma Global for $1.4 billion, launching PNT stock to a two-year high.

Investors Business Daily

Point Biopharma stock soars on $1.4B takeover bid from Eli Lilly

Eli Lilly will add to its growing oncology business with the $1.4 billion takeover of Point Biopharma Global

The Street

These 5 Stocks Are Setting Up This Buying Opportunity After Strong Runs

After a run, stocks can offer a new buying opportunity with a pullback to the 50-day line. Novo Nordisk and 4 S&P 500 stocks have done that.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

7 Stocks Soar More Than 90% Even As Fed Hikes Rates

Who says higher interest rates are bad for S&P 500 stocks? A select group is thriving even as the Federal Reserve hikes.

Barchart

Here's What $1,000 Invested in Eli Lilly 10 Years Ago Would Be Worth Now

Eli Lilly stock has surged over 1,200% in the last 10 years. Here's why I remain bullish on this blue-chip healthcare stock right now.

The Conversation

Mounjaro: type 2 diabetes drug more effective than Ozempic to launch in the UK — here’s what you need to know

A new drug to treat type 2 diabetes has been approved for use) in the UK. Tirzepatide (sold under the brand name Mounjaro) could be available for prescription by early 2024 – subject to availability.

The Guardian - UK

Wegovy: the slimming drug that keeps Denmark’s economy growing

Novo Nordisk, the maker of the blockbuster obesity injection, has singlehandedly saved the country from recession

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

'Smart Money' Investors Pour $2 Billion Into Just 5 Stocks

If you're wondering which S&P 500 stocks the best mutual funds are buying — you might be surprised how selective the list is.

Investors Business Daily

How Stocks Pass Quality Test Of This Best Mutual Fund

It doesn't take a Ph.D. in finance to figure out what the investing game plan is for GMO Quality IV Fund, a best mutual fund.

The Independent UK

Another weight loss jab approved for NHS use

The once-weekly jab was hailed as a ‘much-needed addition to other available treatments’

The Independent UK

Weight loss jab recommended to treat type 2 diabetes

The once-weekly jab was hailed as a ‘much-needed addition to other available treatments’

Barchart

Chart of the Day: Eli Lilly (LLY) Edges to New Record High

The Barchart Chart of the Day belongs to Eli Lilly (LLY) . I found the stock by using Barchart.com to find the "Barchart New Highs" page, and then I clicked on pull-down to select stocks with new 52-week highs. I then viewed the stocks on the list with the FlipCharts...

Investors Business Daily

Warren Buffett Bets His Fortune On One Of 9 'Can't Lose' Stocks

What do investors do when they can get 5% for taking no risk? Find S&P 500 stocks they can make even more on by taking little risk — a tall order only a few can meet.

Investors Business Daily

How Novo Nordisk, A Top 1% Stock, Just Hit Another Bull's-eye In Obesity Treatment

Novo Nordisk said Friday its obesity treatment, Wegovy, reduced heart-failure symptoms. But Novo Nordisk stock remained flat.

1 … 14 15 16 17

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations